We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

1 hedge funds and large institutions have $52K invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 297 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 298 → 1 (-297)

100% less funds holding in top 10

Funds holding in top 10: 47 → 0 (-47)

100% less capital invested

Capital invested by funds: $10.8B → $52K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 297

Holders
1
Holders Change
-297
Holders Change %
-99.66%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-47
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
297
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
-$950M
2
PCM
Pentwater Capital Management
Florida
-$652M
3
State Street
State Street
Massachusetts
-$376M
4
YCMGA
York Capital Management Global Advisors
New York
-$327M
5
BIT
BlackRock Institutional Trust
California
-$317M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
– -$62M -358,907 Closed
Geode Capital Management
52
Geode Capital Management
Massachusetts
– -$61.4M -355,386 Closed
TCA
53
Taconic Capital Advisors
New York
– -$60.5M -350,000 Closed
GCL
54
Glazer Capital LLC
New York
– -$53.7M -310,700 Closed
Barclays
55
Barclays
United Kingdom
– -$52.3M -303,956 Closed
AIM
56
Allen Investment Management
New York
– -$51.8M -300,000 Closed
D.E. Shaw & Co
57
D.E. Shaw & Co
New York
– -$44.7M -258,455 Closed
GCIA
58
Gabelli & Co Investment Advisers
New York
– -$44.5M -257,763 Closed
OAM
59
Oxford Asset Management
United Kingdom
– -$44.4M -256,800 Closed
PP
60
Paloma Partners
Connecticut
– -$43.2M -250,000 Closed
California Public Employees Retirement System
61
California Public Employees Retirement System
California
– -$31M -245,531 Closed
Credit Agricole
62
Credit Agricole
France
– -$41.6M -240,551 Closed
GC
63
Guggenheim Capital
Illinois
– -$39.5M -228,782 Closed
BG
64
BlackRock Group
United Kingdom
– -$38.8M -224,474 Closed
CC
65
Coastland Capital
California
– -$38.2M -221,300 Closed
SFM
66
Soros Fund Management
New York
– -$34.9M -201,903 Closed
SCM
67
Steadfast Capital Management
New York
– -$33.1M -191,778 Closed
CC
68
Clearline Capital
New York
– -$32.1M -185,851 Closed
CS
69
Credit Suisse
Switzerland
– -$31.6M -182,992 Closed
Schroder Investment Management Group
70
Schroder Investment Management Group
United Kingdom
– -$31.6M -182,800 Closed
FMA
71
FNY Managed Accounts
New York
– -$31.2M -180,357 Closed
BIM
72
BlackRock Investment Management
Delaware
– -$31.1M -179,891 Closed
Principal Financial Group
73
Principal Financial Group
Iowa
– -$30.7M -177,655 Closed
BPGAM
74
BTG Pactual Global Asset Management
Bermuda
– -$30.7M -177,524 Closed
Sumitomo Mitsui Trust Group
75
Sumitomo Mitsui Trust Group
Japan
– -$28.9M -167,227 Closed
1 2
3
4 5

SLXP Hedge Fund Activity: Q2 2015 in Review

1 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2015, worth a combined $52K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 297 funds closed out of SLXP and 0 opened new positions — a net loss of 297 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Paulson & Co, exiting entirely with an estimated $950M sold.

  • 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2015, down from 298 in Q1 2015.
  • Funds reported $52K of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2015 and 297 closed out, a net change of -297 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q2 2015 was Paulson & Co, an estimated $950M sold.

Based on aggregated 13F filings for Q2 2015.